Home › Companies › Aurinia Pharmaceuticals Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Aurinia Pharmaceuticals Inc.’s Form 8-K, filed 2026-06-04 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore Aurinia Pharmaceuticals Inc. in the interactive database Compare manager voting policies
These tallies are Aurinia Pharmaceuticals Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Kevin Tang | 68,889,411 | -- | -- | 2,434,090 | 16,049,984 | Majority: yes |
| Elect Director: Jeffrey Bailey | 67,990,723 | -- | -- | 3,332,778 | 16,049,984 | Majority: yes |
| Elect Director: Kathy Goetz | 68,840,807 | -- | -- | 2,482,694 | 16,049,984 | Majority: yes |
| Elect Director: Craig Johnson | 61,694,786 | -- | -- | 9,628,715 | 16,049,984 | Majority: yes |
| Elect Director: Tina S. Nova | 61,972,942 | -- | -- | 9,350,560 | 16,049,983 | Majority: yes |
| Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm until the annual general meeting of shar | 77,785,132 | -- | -- | 9,488,350 | 3 | Majority: yes |
| Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation. | 66,398,971 | 4,315,143 | 609,384 | -- | 16,049,987 | Majority: yes |
Source: Aurinia Pharmaceuticals Inc., Form 8-K, filed with the SEC on 2026-06-04 — read the filing on EDGAR.
Each item below shows how the 259 asset managers that disclosed a Aurinia Pharmaceuticals Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Aurinia Pharmaceuticals Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 50.8% for, 3% against (54.1% of the company cast a for/against vote).
The 185 asset managers below cast 97% of the shares they voted on this item FOR (32,211,233 for, 1,021,611 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 3,969,834 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2,408,157 | 0 | 0 | 0 | For |
| Fidelity | 2,123,743 | 0 | 0 | 0 | For |
| State Street | 2,002,808 | 0 | 0 | 0 | For |
| Two Sigma | 1,822,991 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,541,858 | 0 | 0 | 0 | For |
| Vanguard | 1,496,658 | 5 | 1 | 0 | For |
| Janus Henderson | 1,428,424 | 0 | 0 | 0 | For |
| Charles Schwab | 908,260 | 0 | 0 | 0 | For |
| Renaissance | 850,227 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 831,547 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 803,419 | 0 | 0 | 0 | For |
| American Century | 725,509 | 0 | 0 | 0 | For |
| Goldman Sachs | 721,247 | 0 | 0 | 0 | For |
| DE Shaw | 713,789 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 691,472 | 0 | 0 | 0 | For |
| Prudential/PGIM | 673,510 | 0 | 0 | 0 | For |
| Nuveen | 636,948 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| AQR | 504,210 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 350,794 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 350,562 | 0 | 0 | Against |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 275,300 | 0 | 0 | 0 | For |
| Invesco | 0 | 268,351 | 0 | 0 | Against |
Showing the 25 largest of 185 asset managers. See all 185 in the interactive database.
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 50.8% for, 3% against (54.1% of the company cast a for/against vote).
The 64 asset managers below cast 99.9% of the shares they voted on this item FOR (9,982,991 for, 2,870 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,035,627 | 2,870 | 0 | 0 | For |
| Northern Trust | 693,696 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 608,318 | 0 | 0 | 0 | For |
| Goldman Sachs | 322,986 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 244,292 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 236,688 | 0 | 0 | 0 | For |
| WELLS FARGO ADVISORS FINANCIAL NETWORK, LLC | 234,639 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 81,244 | 0 | 0 | 0 | For |
| Capital Investment Advisors, LLC | 33,750 | 0 | 0 | 0 | For |
| John Hancock | 30,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,949 | 0 | 0 | 0 | For |
| Acropolis Investment Management, LLC | 19,657 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 12,711 | 0 | 0 | 0 | For |
| Corient Private Wealth LP | 12,622 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 11,367 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 10,085 | 0 | 0 | 0 | For |
| GRIMES & Co WEALTH MANAGEMENT, LLC | 9,830 | 0 | 0 | 0 | For |
| US BANK NATIONAL ASSOCIATION | 8,820 | 0 | 0 | 0 | For |
| OPPENHEIMER & CO INC | 8,420 | 0 | 0 | 0 | For |
| First Bank & Trust | 6,536 | 0 | 0 | 0 | For |
| Focus Partners Wealth | 6,000 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 4,223 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 3,452 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.
Combines 5 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm ”): 77,785,132 for, 9,488,350 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 59% for, 7% withheld (67% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (12,626,381 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,261,979 | 0 | 911 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 83,000 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | For |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kevin Tang”): 68,889,411 for, 2,434,090 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.7% for, 2% withheld (54.5% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (12,674,559 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,886 | 0 | 3 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | For |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 2 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Craig Johnson”): 61,694,786 for, 9,628,715 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 47.2% for, 7% withheld (54.5% of the company cast a for/withheld vote).
The 54 asset managers below cast 100% of the shares they voted on this item FOR (7,786,782 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,261,979 | 0 | 911 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | For |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Jeffrey Bailey”): 67,990,723 for, 3,332,778 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.0% for, 3% withheld (54.5% of the company cast a for/withheld vote).
The 54 asset managers below cast 100% of the shares they voted on this item FOR (7,777,061 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,261,987 | 0 | 903 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | For |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kathy Goetz”): 68,840,807 for, 2,482,694 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.6% for, 2% withheld (54.5% of the company cast a for/withheld vote).
The 54 asset managers below cast 100% of the shares they voted on this item FOR (7,777,960 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,886 | 0 | 3 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | For |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 2 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Tina S. Nova”): 61,972,942 for, 9,350,560 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 47.4% for, 7% withheld (54.5% of the company cast a for/withheld vote).
The 54 asset managers below cast 100% of the shares they voted on this item FOR (7,777,951 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,877 | 0 | 12 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | For |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
97% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kevin Tang”): 68,889,411 for, 2,434,090 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.7% for, 2% withheld (54.5% of the company cast a for/withheld vote).
The 9 asset managers below cast 100% of the shares they voted on this item FOR (4,896,599 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| John Hancock | 30,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,949 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 12,711 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 4,223 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 3,264 | 0 | 0 | 0 | For |
| ETF Opportunities Trust | 0 | 0 | 0 | 0 | -- |
97% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kevin Tang”): 68,889,411 for, 2,434,090 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.7% for, 2% withheld (54.5% of the company cast a for/withheld vote).
The 9 asset managers below cast 100% of the shares they voted on this item FOR (4,896,599 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| John Hancock | 30,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,949 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 12,711 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 4,223 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 3,264 | 0 | 0 | 0 | For |
| ETF Opportunities Trust | 0 | 0 | 0 | 0 | -- |
97% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kevin Tang”): 68,889,411 for, 2,434,090 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.7% for, 2% withheld (54.5% of the company cast a for/withheld vote).
The 9 asset managers below cast 100% of the shares they voted on this item FOR (4,896,599 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| John Hancock | 30,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,949 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 12,711 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 4,223 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 3,264 | 0 | 0 | 0 | For |
| ETF Opportunities Trust | 0 | 0 | 0 | 0 | -- |
97% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kevin Tang”): 68,889,411 for, 2,434,090 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 52.7% for, 2% withheld (54.5% of the company cast a for/withheld vote).
The 9 asset managers below cast 100% of the shares they voted on this item FOR (4,896,599 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| John Hancock | 30,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,949 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 12,711 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 4,223 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 3,264 | 0 | 0 | 0 | For |
| ETF Opportunities Trust | 0 | 0 | 0 | 0 | -- |
94% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 50.8% for, 3% against (54.1% of the company cast a for/against vote).
The 8 asset managers below cast 26% of the shares they voted on this item FOR (109,699 for, 308,247 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 292,200 | 0 | 0 | Against |
| Uniplan Investment Counsel, Inc. | 94,656 | 0 | 0 | 0 | For |
| Union Investment Management GmbH | 0 | 16,047 | 0 | 0 | Against |
| Cornerstone Investment Partners, LLC | 13,119 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 1,143 | 0 | 0 | 0 | For |
| Fischer Financial Services, Inc. | 500 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 181 | 0 | 0 | 0 | For |
| Wilshire Advisors LLC | 100 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 50.8% for, 3% against (54.1% of the company cast a for/against vote).
The 4 asset managers below cast 100% of the shares they voted on this item FOR (12,467,145 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 12,229,500 | 0 | 0 | 0 | For |
| Woodline Partners LP | 237,503 | 0 | 0 | 0 | For |
| Blueprint Financial Advisors LLC | 142 | 0 | 0 | 0 | For |
| Verdad Advisers, LP | 0 | 0 | 0 | 0 | -- |
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,771,000 outstanding shares: 50.8% for, 3% against (54.1% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,803 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janney Montgomery Scott LLC | 2,153 | 0 | 0 | 0 | For |
| Rempart Asset Management Inc. | 650 | 0 | 0 | 0 | For |
Ranked by the number of Aurinia Pharmaceuticals Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 130,771,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | NEA Management Company, LLC | 3.04% |
| 2 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.84% |
| 3 | Fidelity | 1.62% |
| 4 | State Street | 1.53% |
| 5 | Two Sigma | 1.39% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.18% |
| 7 | Vanguard | 1.14% |
| 8 | Janus Henderson | 1.09% |
| 9 | Charles Schwab | 0.69% |
| 10 | Renaissance | 0.65% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 6.00% | 13F |
| Chin Kyu Huh | 4.52% | 13D |
| Two Sigma | 2.62% | 13F |
| State Street | 1.93% | 13F |
| Morgan Stanley | 1.70% | 13F |
| Renaissance Technologies | 1.27% | 13F |
| D.E. Shaw | 1.20% | 13F |
| Geode Capital | 1.17% | 13F |
| Vanguard Group | 1.11% | 13F |
| Goldman Sachs | 1.10% | 13F |
Percentages above are of 130,771,000 shares outstanding, as reported by Aurinia Pharmaceuticals Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Aurinia Pharmaceuticals Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At Aurinia Pharmaceuticals Inc.'s shareholder meeting held 2026-06-03, in the 2025-2026 proxy season, 259 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,478 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Aurinia Pharmaceuticals Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-04.
Aurinia Pharmaceuticals Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).